Drug utilization review

Luo, N. et al. (2004). Drug utilization review of risperidone for outpatients in a tertiary referral hospital in Singapore. Hum. Psychopharmacol, 19, 259-64. 

DC Brodie. Drug utilization review/planning. Am J Pub Health 46 103, 1972. 

Focused drug use evaluation (drug utilization review) can be done to identify problems concerning the use of specific medicines or the treatment of specific diseases, particularly in hospitals. The qualitative methods employed in social science (e.g. focus group discussion, in-depth interviews, structured observation and structured questionnaires), can be used to investigate the motives underlying irrational use. All data collected should be used to design interventions and to measure the impact of those interventions on medicine use. 

Motola G, Mazzeo F, Rinaldi B, et al. Self-prescribed laxative use a drug-utilization review. Adv Ther. 2002 19 203-238. 

Antipsychotic drug therapy poses hazards for elderly. (1988). Drug Utilization Review, 4, 73-84. 

Brodie DC, Smith WE. Constructing a conceptual model of drug utilization review. Hospitals 1976 50 143-150. 

Kubacka RT. A primer on drug utilization review. /. Am. Pharm. Assoc. 1996 NS(4) 257-261. 

Quality management, drug utilization review, and data collection... 

Drug utilization review Pharmacokinetic monitoring Drug formulary management Pain management Drug research and studies Nutrition... 

If one asks the question, What is my computer supposed to be doing when I m providing pharmaceutical care the answer will not only describe the appropriate hardware or device that matches the needs of the professional providing the care, but should also describe the optimal software that will support the provision of pharmaceutical care. We define the point-of-care as the place where a pharmacist provides pharmaceutical care to a patient or assists a colleague (pharmacist, physician, or nurse) in the provision of care. Many kinds of software available on the market today focus solely on transaction processing, with minimal decision support available through prospective drug utilization review (DUR) modules. 

Clinicians will often desire to examine historical data or use relevant references, or primary or secondary literature sources. The software design should include these aspects at a minimum. When prospective drug utilization review flags are presented, false positive warnings should be minimal to prevent practitioners from getting in the habit... 

At a state level, drug information practitioners may be involved with drug utilization review, whereby data on drug usage patterns is collected and analyzed to determine ways by which drug therapy may be improved. 

Pharmacies and physicians will need to spend less time contacting each other and insurance companies to overcome formulary restrictions and problems found upon drug utilization review, and to clarify illegible handwriting. 

Several collaborative studies, particularly in the field of drug utilization review and drug evaluation, among member countries have been or are still in progress. 

With Rx Inhand , developers have a powerful tool for creating stand-alone handheld applications. This drug navigation and drug utilization review (DUR) engine enables developers to easily create systems for use by physicians to write prescriptions and to screen them on a handheld device for possible medication errors, thus potentially minimizing adverse medical events. 

Monane, M. Matthias, D.M. Nagle, B.A. Kelly, M.A. Improving prescribing patterns for the elderly through an online drug utilization review intervention A system linking the physician, pharmacist, and computer. J. Am. Med. Assoc. 1998, 280 (14), 1249-1252. 

That drug utilization review programs be integrated into medical CE. 

Canada has the dubious distinction of having the world s largest per capita consumption of precursor opiate-containing compounds (e g., codeine, oxycodone, and hydrocodone) (Korcok 1979). A drug utilization review of opiate use in Canada from 1978 to 1989 shows continued increase in the use of prescribed codeine combination products. The defined daily dose (DDD)/1000 inhabitants/day for prescribed codeine-acetaminophen products has increased from 3.3 DDD/1000 inhabitants/day in 1982 to 8.1 DDD/1000 inhabitants/day in 1989. Oxycodone-acetaminophen containing products have also been increasing from 0.04 DDD/1000 inhabitants/day in 1978 to 0.21... 

---